Kidokoro et al. [19] demonstrated that CDC20 repression mediates the tumor suppressive function of p53. These findings are in-line with p53 inactivation observed in various cancer tissues including glioma, lung cancer, and breast ductal carcinoma and is likely due to CDC20 up-regulation [19]. This evidence concerns the gene TP53 and central nervous system cancer.